Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2018 Feb 7;16(7):1073–1080.e1. doi: 10.1016/j.cgh.2018.01.046

Table 4.

Predictors of Early Removal and Tolerance at < 8 weeks

Variable Odds Ratio ( 95% CI; p value)
Univariable Multivariablea

Age 0.97 (0.93–1.009; p=0.16) 0.97 (0.93–1.01; p = 0.19)

Gender (female) 1.54 (0.56–3.83; p= 0.37) 1.40 (0.5–3.53; p=0.48)

Depression comorbidity 2.71 (0.83–8.44; p=0.09) 2.31 (0.69–7.76; p=0.16)

SSRI/SNRI medication 3.92 (1.2412.41; p=0.02) 3.32 (1.0110.88; p=0.046)

Prior GERD 2.94 (0.94–9.18; p=0.06) 2.14 (0.62–7.26; p=0.22)

Aprepitant use 0.41 (0.17–0.99; p=0.049) 0.42 (0.17–1.01); p=0.0528
a

adjusted for age and gender